Keun Young Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Keun Young Park has a total of 294 co-authors. Here are the top co-authors by number of shared publications:
- Dong Joon Kim
Department of Radiology, Yonsei University College of Medicine, Seoul, Korea
13 shared publications - Yong Bae Kim
Department of Neurosurgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
13 shared publications - Byung Moon Kim
Department of Radiology, Yonsei University College of Medicine, Seoul, Korea
12 shared publications - Joonho Chung
Department of Neurosurgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
11 shared publications - Jae Whan Lee
Department of Neurosurgery, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea
10 shared publications - Hyun Jin Han
Department of Neurosurgery, Severance Stroke Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
8 shared publications
Latest Publications
- Open Access
- 18 November 2026
- Published by Springer Nature in Neuroradiology
Endovascular coiling with Target Tetra® Detachable Coils for small (≤ 5 mm) intracranial aneurysms: a prospective single-center registry study
- 18 November 2026
- Published by Springer Nature in Neuroradiology
Open AccessEndovascular coiling with Target Tetra® Detachable Coils for small (≤ 5 mm) intracranial aneurysms: a prospective single-center registry study
- 12 June 2026
- Published by Bentham Science Publishers Ltd. in Current Neurovascular Research
- Vol. 23
Retrospective External Validation of the ELAPSS Score for the Prediction of Unruptured Intracranial Aneurysm Growth Risk
Introduction:: This study aimed to evaluate the accuracy of the Earlier Subarachnoid Hemorrhage, Aneurysm Location, Age, Population, Aneurysm Size, And Shape (ELAPSS) score in predicting the growth risk of unruptured intracranial aneurysms across different patient subgroups. Methods:: Between 2002 and 2021, we retrospectively included patients with saccular intracranial aneurysms who underwent at least two serial angiographic imaging studies at a single tertiary center. Imaging modalities included computed tomography angiography, magnetic resonance angiography, and digital subtraction angiography, with a minimum follow-up of six months. ELAPSS score components were recorded at diagnosis, and absolute growth risks at 3, 5, 10, 15, and 16 years were calculated. Results:: A total of 483 patients with 563 aneurysms were analyzed, accounting for 2,766 aneurysm- years of follow-up. Aneurysm growth was observed in 86 aneurysms (15.2%). Over a 16- year follow-up period, cumulative growth risk was significantly lower in the low-risk group compared with the intermediate- and high-risk groups. Discussion:: Although the ELAPSS score demonstrated long-term risk stratification for aneurysm growth, heterogeneity in patient and aneurysm characteristics may limit its accuracy for individualized clinical decision-making. Conclusion:: This external validation study suggests that caution is warranted when applying the ELAPSS score to guide treatment decisions for unruptured intracranial aneurysms.
- 12 June 2026
- Published by Bentham Science Publishers Ltd. in Current Neurovascular Research
- Vol. 23
Retrospective External Validation of the ELAPSS Score for the Prediction of Unruptured Intracranial Aneurysm Growth Risk
Introduction:: This study aimed to evaluate the accuracy of the Earlier Subarachnoid Hemorrhage, Aneurysm Location, Age, Population, Aneurysm Size, And Shape (ELAPSS) score in predicting the growth risk of unruptured intracranial aneurysms across different patient subgroups. Methods:: Between 2002 and 2021, we retrospectively included patients with saccular intracranial aneurysms who underwent at least two serial angiographic imaging studies at a single tertiary center. Imaging modalities included computed tomography angiography, magnetic resonance angiography, and digital subtraction angiography, with a minimum follow-up of six months. ELAPSS score components were recorded at diagnosis, and absolute growth risks at 3, 5, 10, 15, and 16 years were calculated. Results:: A total of 483 patients with 563 aneurysms were analyzed, accounting for 2,766 aneurysm- years of follow-up. Aneurysm growth was observed in 86 aneurysms (15.2%). Over a 16- year follow-up period, cumulative growth risk was significantly lower in the low-risk group compared with the intermediate- and high-risk groups. Discussion:: Although the ELAPSS score demonstrated long-term risk stratification for aneurysm growth, heterogeneity in patient and aneurysm characteristics may limit its accuracy for individualized clinical decision-making. Conclusion:: This external validation study suggests that caution is warranted when applying the ELAPSS score to guide treatment decisions for unruptured intracranial aneurysms.
- Open Access
- 14 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
The association of first follow-up blood pressure level with recurrent stroke and mortality in survivors of spontaneous intracerebral hemorrhage
Although blood pressure is an important modifiable factor for the prevention of recurrent stroke after spontaneous intracerebral hemorrhage (ICH), the target blood pressure remains uncertain. Using the National Health Insurance Service database from January 2005 to December 2022, patients who survived for more than one year with prescribed antihypertensive drugs were identified. We compared the risks of mortality, ischemic stroke, and recurrent ICH among six groups divided according to systolic blood pressure (SBP). SBP was assessed at the first available health examination within 1 year after the index ICH and the date of SBP measurement was defined as the index date.The incidence rates, hazard ratios, and 95% confidence intervals were estimated using the Cox proportional hazards model. Among the 11,034 ICH survivors, 5-year incidence rates of mortality, ischemic stroke, and recurrent ICH were 13.26 per 1000 person-year, 7.71, and 12.90, respectively. Mortality incidence was lowest in the SBP 120-129 mmHg group, and SBP ≥ 160 mmHg was associated with a higher risk of mortality (adjusted HR [aHR]: 1.55 [95% CI 1.06-2.28]) compared with the reference group. Acute ischemic stroke followed linear increasing trend with significance at SBP ≥ 150 mmHg (SBP 150-159 mmHg, aHR: 1.80 [95% CI 1.18-2.74]), while recurrent ICH was significantly increased at SBP ≥ 160 mmHg (aHR: 1.87 [95% CI 1.27-2.74]). The present study showed that SBP between 120-129 mmHg was associated with the lowest risk of mortality, while higher SBP levels were associated with increased risk of ischemic stroke and ICH recurrence. These findings suggest a designated blood pressure range for managing this high-risk population.
- 14 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessThe association of first follow-up blood pressure level with recurrent stroke and mortality in survivors of spontaneous intracerebral hemorrhage
Although blood pressure is an important modifiable factor for the prevention of recurrent stroke after spontaneous intracerebral hemorrhage (ICH), the target blood pressure remains uncertain. Using the National Health Insurance Service database from January 2005 to December 2022, patients who survived for more than one year with prescribed antihypertensive drugs were identified. We compared the risks of mortality, ischemic stroke, and recurrent ICH among six groups divided according to systolic blood pressure (SBP). SBP was assessed at the first available health examination within 1 year after the index ICH and the date of SBP measurement was defined as the index date.The incidence rates, hazard ratios, and 95% confidence intervals were estimated using the Cox proportional hazards model. Among the 11,034 ICH survivors, 5-year incidence rates of mortality, ischemic stroke, and recurrent ICH were 13.26 per 1000 person-year, 7.71, and 12.90, respectively. Mortality incidence was lowest in the SBP 120-129 mmHg group, and SBP ≥ 160 mmHg was associated with a higher risk of mortality (adjusted HR [aHR]: 1.55 [95% CI 1.06-2.28]) compared with the reference group. Acute ischemic stroke followed linear increasing trend with significance at SBP ≥ 150 mmHg (SBP 150-159 mmHg, aHR: 1.80 [95% CI 1.18-2.74]), while recurrent ICH was significantly increased at SBP ≥ 160 mmHg (aHR: 1.87 [95% CI 1.27-2.74]). The present study showed that SBP between 120-129 mmHg was associated with the lowest risk of mortality, while higher SBP levels were associated with increased risk of ischemic stroke and ICH recurrence. These findings suggest a designated blood pressure range for managing this high-risk population.
- Open Access
- 1 January 2026
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 83 (1) , 35
Burden of Central Nervous System Cancer in the United States, 1990-2021
Importance: Primary brain and central nervous system cancer (collectively referred to as CNS cancer) comprises 2% of all human cancers and poses significant health and economic challenges in the United States. Objective: To analyze CNS cancer burden in the US, stratified by time, location (state and division), sex, age group, and Sociodemographic Index (SDI). Design, Setting, and Participants: This cross-sectional study involved a repeated analysis of Global Burden of Disease Study (GBD) 2021 data in 2024. Using data from 183 sources, CNS cancer metrics in the US were estimated across states and years. US CNS cancer metrics across all sexes and age groups were included in the GBD. Exposure: CNS cancer diagnosis. Main Outcomes and Measures: Overall and age-standardized estimates of the incidence, prevalence, mortality, disability-adjusted life-years (DALYs), years of life lost, and years lived with disability per 100 000 population, including 95% uncertainty intervals (UIs), and time trends. Results: In 2021, for all age groups and sexes across the US, there were 31 780 incident cases (95% UI, 29971.1 to 32843.9). Age-standardized incidence, DALYs, and mortality rates per 100 000 population were 6.91 (95% UI, 6.58 to 7.12), 134.38 (95% UI, 129.83 to 137.95), and 4.1 (95% UI, 3.87 to 4.22), respectively. Despite no significant change observed in the overall incidence between 1990 and 2021, DALY and mortality rates decreased by 15.77% (95% UI, −17.75% to −13.68%) and 8.41% (95% UI, −11.09% to −6.22%), respectively. Substantial geographic variability was noted. Mississippi, Alabama, Kentucky, and Kansas (West North Central and East South Central divisions) and West Virginia faced persistently high burdens over the past 30 years. Sex differences were evident; disease burden was consistently higher in males compared with females. Age-specific estimates showed a bimodal distribution: the youngest group (70 years) experienced increasing trends. DALYs and mortality rates were negatively correlated with SDI (ρ = −0.6860 and ρ = −0.6391; P < .001). Conclusions and Relevance: These findings provide valuable insights into the CNS cancer burden across the US by age, sex, location, and SDI, enabling better public health status assessments, health care policy restructuring, and resource redistribution for improved care.
- 1 January 2026
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 83 (1) , 35
Open AccessBurden of Central Nervous System Cancer in the United States, 1990-2021
Importance: Primary brain and central nervous system cancer (collectively referred to as CNS cancer) comprises 2% of all human cancers and poses significant health and economic challenges in the United States. Objective: To analyze CNS cancer burden in the US, stratified by time, location (state and division), sex, age group, and Sociodemographic Index (SDI). Design, Setting, and Participants: This cross-sectional study involved a repeated analysis of Global Burden of Disease Study (GBD) 2021 data in 2024. Using data from 183 sources, CNS cancer metrics in the US were estimated across states and years. US CNS cancer metrics across all sexes and age groups were included in the GBD. Exposure: CNS cancer diagnosis. Main Outcomes and Measures: Overall and age-standardized estimates of the incidence, prevalence, mortality, disability-adjusted life-years (DALYs), years of life lost, and years lived with disability per 100 000 population, including 95% uncertainty intervals (UIs), and time trends. Results: In 2021, for all age groups and sexes across the US, there were 31 780 incident cases (95% UI, 29971.1 to 32843.9). Age-standardized incidence, DALYs, and mortality rates per 100 000 population were 6.91 (95% UI, 6.58 to 7.12), 134.38 (95% UI, 129.83 to 137.95), and 4.1 (95% UI, 3.87 to 4.22), respectively. Despite no significant change observed in the overall incidence between 1990 and 2021, DALY and mortality rates decreased by 15.77% (95% UI, −17.75% to −13.68%) and 8.41% (95% UI, −11.09% to −6.22%), respectively. Substantial geographic variability was noted. Mississippi, Alabama, Kentucky, and Kansas (West North Central and East South Central divisions) and West Virginia faced persistently high burdens over the past 30 years. Sex differences were evident; disease burden was consistently higher in males compared with females. Age-specific estimates showed a bimodal distribution: the youngest group (70 years) experienced increasing trends. DALYs and mortality rates were negatively correlated with SDI (ρ = −0.6860 and ρ = −0.6391; P < .001). Conclusions and Relevance: These findings provide valuable insights into the CNS cancer burden across the US by age, sex, location, and SDI, enabling better public health status assessments, health care policy restructuring, and resource redistribution for improved care.
- 11 December 2025
- Published by Springer Nature in Neuroradiology
- Vol. 68 (3) , 807-814
Optimal device-to-aneurysm ratio and one-year radiological outcomes of volume-based woven endobridge selection
Background The woven EndoBridge (WEB) device has been introduced for the treatment of wide-neck bifurcation aneurysms; however, device selection remains a major challenge inWEB treatment. This study aimed to demonstrate the effectiveness of WEB selection using volumetric analysis and its 1-year radiological outcomes. Methods We retrospectively analysed patients with unruptured wide-neck bifurcation aneurysms who underwent WEB treatment between August 2021 and January 2023. Aneurysm volume was measured semi-automatically using a three-dimensional volume-rendering programme. Radiological outcomes were analysed using the WEB Occlusion Scale (WOS) at 1-year catheter angiography follow-up. Receiver operating characteristic (ROC) curve analysis was conducted to evaluate the prognostic performance of the device-to-aneurysm volume (DAV) ratio for predicting complete occlusion. Univariate and multivariate analyses were performed to assess the predictive factors for complete occlusion. Results Fifty-seven unruptured intracranial aneurysms, in 56 patients were treated with the WEB device. The device was changed in 14 patients (24.6%) following the + 1/-1 rule, and volume-based recommendations were appropriate for all patients. At the 1-year follow-up, complete occlusion (WOS A and B) was confirmed in 35 patients (61.4%), and adequate occlusion (WOS A, B, and C) was confirmed in 87.7% (50 of 57 patients). The ROC curve analysis showed a significant relationship for 1-year complete occlusion (area under the curve: 0.74, 95% confidence interval [CI]: 0.59–0.88) with an optimal cut-off of 0.92. The DAV ratio was the only significant predictive factor for 1-year complete occlusion in the univariate (odds ratio [OR]: 7.0, 95% CI: 2.20–24.7, p = 0.001) and multivariate (OR: 20.39, 95% CI: 3.56–111.73, p = 0.0007) analyses. Conclusions Volume-based WEB selection was appropriate for initial device selection and 1-year radiological outcomes. The selection of a WEB device with a volume exceeding 92% of that of the targeted aneurysm could be considered for 1-year radiological outcomes.
- 11 December 2025
- Published by Springer Nature in Neuroradiology
- Vol. 68 (3) , 807-814
Optimal device-to-aneurysm ratio and one-year radiological outcomes of volume-based woven endobridge selection
Background The woven EndoBridge (WEB) device has been introduced for the treatment of wide-neck bifurcation aneurysms; however, device selection remains a major challenge inWEB treatment. This study aimed to demonstrate the effectiveness of WEB selection using volumetric analysis and its 1-year radiological outcomes. Methods We retrospectively analysed patients with unruptured wide-neck bifurcation aneurysms who underwent WEB treatment between August 2021 and January 2023. Aneurysm volume was measured semi-automatically using a three-dimensional volume-rendering programme. Radiological outcomes were analysed using the WEB Occlusion Scale (WOS) at 1-year catheter angiography follow-up. Receiver operating characteristic (ROC) curve analysis was conducted to evaluate the prognostic performance of the device-to-aneurysm volume (DAV) ratio for predicting complete occlusion. Univariate and multivariate analyses were performed to assess the predictive factors for complete occlusion. Results Fifty-seven unruptured intracranial aneurysms, in 56 patients were treated with the WEB device. The device was changed in 14 patients (24.6%) following the + 1/-1 rule, and volume-based recommendations were appropriate for all patients. At the 1-year follow-up, complete occlusion (WOS A and B) was confirmed in 35 patients (61.4%), and adequate occlusion (WOS A, B, and C) was confirmed in 87.7% (50 of 57 patients). The ROC curve analysis showed a significant relationship for 1-year complete occlusion (area under the curve: 0.74, 95% confidence interval [CI]: 0.59–0.88) with an optimal cut-off of 0.92. The DAV ratio was the only significant predictive factor for 1-year complete occlusion in the univariate (odds ratio [OR]: 7.0, 95% CI: 2.20–24.7, p = 0.001) and multivariate (OR: 20.39, 95% CI: 3.56–111.73, p = 0.0007) analyses. Conclusions Volume-based WEB selection was appropriate for initial device selection and 1-year radiological outcomes. The selection of a WEB device with a volume exceeding 92% of that of the targeted aneurysm could be considered for 1-year radiological outcomes.
- 2 December 2025
- Published by Springer Nature in Neuroradiology
- Vol. 68 (3) , 795-806
Predictors of clinical and angiographic outcomes after woven EndoBridge treatment for intracranial aneurysms: an asian multicenter cohort study
Purpose The Woven EndoBridge (WEB) device is an intrasaccular flow disruptor designed for the treatment of wide-neck intracranial bifurcation aneurysms. The purpose of this study was to evaluate various factors associated with clinical and angiographic outcomes following WEB treatment. Methods This multicenter, retrospective study analyzed 405 patients with 412 aneurysms treated with the WEB device across 22 neurovascular centers. Clinical and radiologic data were reviewed to identify factors influencing patients’ clinical outcome and target aneurysmal occlusion at short-term (within 6 months) and long-term (beyond 1 year) follow-up. Occlusion status of target aneurysms was analyzed in relation to the various clinical and morphological factors. Outcomes were also compared based on institutional treatment volume. Results Centers with higher WEB treatment volumes (more than 30 cases) demonstrated lower thromboembolic events with sequelae (0.8% vs. 5.9%, p = 0.003). The rate of aneurysmal adequate occlusion, defined by Raymond-Roy occlusion class 1 and 2, increased from 70.2% at short-term (mean, 133 ± 42 days) to 83.2% at long-term (mean, 499 ± 134 days) follow-up (p = 0.003). Aneurysm diameter was inversely correlated with complete occlusion, with a 6-mm cutoff identified. Wide-neck aneurysms exhibited lower occlusion rates at short-term period, but this effect was not observed at later periods. Aneurysms at the basilar apex and internal carotid artery terminus demonstrated higher rates of complete occlusion (p = 0.046). Smoking acted as an inhibitor of long-term occlusion of target aneurysms. Conclusion Institutional experience appeared to play a role in reducing procedure-related thromboembolic complications. Aneurysmal diameter, neck width, location and patients’ smoking status influenced angiographic outcomes.
- 2 December 2025
- Published by Springer Nature in Neuroradiology
- Vol. 68 (3) , 795-806
Predictors of clinical and angiographic outcomes after woven EndoBridge treatment for intracranial aneurysms: an asian multicenter cohort study
Purpose The Woven EndoBridge (WEB) device is an intrasaccular flow disruptor designed for the treatment of wide-neck intracranial bifurcation aneurysms. The purpose of this study was to evaluate various factors associated with clinical and angiographic outcomes following WEB treatment. Methods This multicenter, retrospective study analyzed 405 patients with 412 aneurysms treated with the WEB device across 22 neurovascular centers. Clinical and radiologic data were reviewed to identify factors influencing patients’ clinical outcome and target aneurysmal occlusion at short-term (within 6 months) and long-term (beyond 1 year) follow-up. Occlusion status of target aneurysms was analyzed in relation to the various clinical and morphological factors. Outcomes were also compared based on institutional treatment volume. Results Centers with higher WEB treatment volumes (more than 30 cases) demonstrated lower thromboembolic events with sequelae (0.8% vs. 5.9%, p = 0.003). The rate of aneurysmal adequate occlusion, defined by Raymond-Roy occlusion class 1 and 2, increased from 70.2% at short-term (mean, 133 ± 42 days) to 83.2% at long-term (mean, 499 ± 134 days) follow-up (p = 0.003). Aneurysm diameter was inversely correlated with complete occlusion, with a 6-mm cutoff identified. Wide-neck aneurysms exhibited lower occlusion rates at short-term period, but this effect was not observed at later periods. Aneurysms at the basilar apex and internal carotid artery terminus demonstrated higher rates of complete occlusion (p = 0.046). Smoking acted as an inhibitor of long-term occlusion of target aneurysms. Conclusion Institutional experience appeared to play a role in reducing procedure-related thromboembolic complications. Aneurysmal diameter, neck width, location and patients’ smoking status influenced angiographic outcomes.
- Open Access
- 3 June 2025
- Published by Springer Nature in BMC Neurology
- Vol. 25 (1) , 1-9
Preliminary results of pravastatin on non-hemorrhagic vertebral artery dissection: an exploratory randomized and controlled study
Background: There is limited information about the pleiotropic effects of statin on cerebrovascular diseases. The authors aimed to investigate the effect of pravastatin on non-hemorrhagic vertebral artery dissection (VAD) in a clinical setting. Methods: An exploratory randomized and controlled study was designed for the non-hemorrhage VAD (CRIS, KCT00035970). Primary outcomes were 1- and 6-month radiologic changes on vessel wall magnetic resonance imaging (VW-MRI), with secondary outcomes related to the clinical and laboratory parameters, and safety outcomes of the pravastatin use. Results: Finally, 23 patients were enrolled, consisting of 12 in the pravastatin group and 11 in the control with similar baseline characteristics except the age (55.0 versus 45.5 years, P = .01). Morphologic changes in the early period (0–1 month) were more improved or resolved in the pravastatin group with a borderline significance (crude odds ratio: 7.500 [95% confidence interval: 0.921-64.047], P = .06). However, age-adjusted analysis showed no difference in morphologic changes between the groups (adjusted odds ratio: 0.853 [95% confidence interval: 0.033-22.020], P = .92). The serum level of high-sensitivity C-reactive protein (hs-CRP) in the pravastatin group showed a descending tendency in the early period (Z-score: -1.843, P = .07), whereas it significantly increased in the control (Z-score: -2.371, P = .02). There were no safety issues at all. Conclusion: Pravastatin had a borderline significant effect on the recovery of non-hemorrhage VAD with no additional adverse effects. A further study with a larger scale is expected to make more concrete evidences about the pleiotropic effects of statin on the non-hemorrhagic VAD. Trial registration: The present study registered in a clinical research information service approved by World Health Organization (CRIS, KCT00035970, Registered on 7 March 2019; available at: https://cris.nih.go.kr/cris/search/detailSearch.do?seq=25234%26status=5%26seq_group=12949%26search_page=M ).
- 3 June 2025
- Published by Springer Nature in BMC Neurology
- Vol. 25 (1) , 1-9
Open AccessPreliminary results of pravastatin on non-hemorrhagic vertebral artery dissection: an exploratory randomized and controlled study
Background: There is limited information about the pleiotropic effects of statin on cerebrovascular diseases. The authors aimed to investigate the effect of pravastatin on non-hemorrhagic vertebral artery dissection (VAD) in a clinical setting. Methods: An exploratory randomized and controlled study was designed for the non-hemorrhage VAD (CRIS, KCT00035970). Primary outcomes were 1- and 6-month radiologic changes on vessel wall magnetic resonance imaging (VW-MRI), with secondary outcomes related to the clinical and laboratory parameters, and safety outcomes of the pravastatin use. Results: Finally, 23 patients were enrolled, consisting of 12 in the pravastatin group and 11 in the control with similar baseline characteristics except the age (55.0 versus 45.5 years, P = .01). Morphologic changes in the early period (0–1 month) were more improved or resolved in the pravastatin group with a borderline significance (crude odds ratio: 7.500 [95% confidence interval: 0.921-64.047], P = .06). However, age-adjusted analysis showed no difference in morphologic changes between the groups (adjusted odds ratio: 0.853 [95% confidence interval: 0.033-22.020], P = .92). The serum level of high-sensitivity C-reactive protein (hs-CRP) in the pravastatin group showed a descending tendency in the early period (Z-score: -1.843, P = .07), whereas it significantly increased in the control (Z-score: -2.371, P = .02). There were no safety issues at all. Conclusion: Pravastatin had a borderline significant effect on the recovery of non-hemorrhage VAD with no additional adverse effects. A further study with a larger scale is expected to make more concrete evidences about the pleiotropic effects of statin on the non-hemorrhagic VAD. Trial registration: The present study registered in a clinical research information service approved by World Health Organization (CRIS, KCT00035970, Registered on 7 March 2019; available at: https://cris.nih.go.kr/cris/search/detailSearch.do?seq=25234%26status=5%26seq_group=12949%26search_page=M ).
- Open Access
- 8 May 2025
- Published by Springer Nature in BMC Neurology
- Vol. 25 (1) , 1-8
Woven endobridge embolization versus microsurgical clipping for unruptured wide-neck cerebral aneurysms on middle cerebral artery bifurcation
Woven EndoBridge (WEB) is an endovascular treatment for wide-neck bifurcation aneurysms (WNBAs). This study aimed to clarify the efficacy and safety of the WEB comparing to clipping for treating the middle cerebral artery (MCA) WNBAs. For the matched analysis, we designed a retrospective, tertiary, single-center study including 288 MCA WNBAs treated with WEB (n = 37) or clipping (n = 251). Inverse probability of treatment weighting (IPTW) for the main analysis and 1:2 propensity score matching for the sensitivity analysis were used to adjust for aneurysm geometric parameters. Morbidity, major complications, and aneurysm occlusion grade were assessed at 1 year. In the IPTW analysis, no significant difference was observed in morbidity (2.1% vs. 1.6%, odds ratio [OR]: 1.34, p = 0.776) and major complications (3.3% vs. 3.1%, OR: 1.08, p = 0.926). Adequate aneurysm occlusion was achieved in 76.1% of the WEB group and 97.4% of the clipping group (OR: 0.09, p < 0.001). In line with the main analysis, the 1:2 propensity score matching analysis revealed no significant difference in the morbidity (OR: 2.00, 95% CI: 0.13–31.98, p = 0.624). This study supports that microsurgical clipping still requires to play a vital role, but WEB could be an alternative option for WNBAs in the MCA.
- 8 May 2025
- Published by Springer Nature in BMC Neurology
- Vol. 25 (1) , 1-8
Open AccessWoven endobridge embolization versus microsurgical clipping for unruptured wide-neck cerebral aneurysms on middle cerebral artery bifurcation
Woven EndoBridge (WEB) is an endovascular treatment for wide-neck bifurcation aneurysms (WNBAs). This study aimed to clarify the efficacy and safety of the WEB comparing to clipping for treating the middle cerebral artery (MCA) WNBAs. For the matched analysis, we designed a retrospective, tertiary, single-center study including 288 MCA WNBAs treated with WEB (n = 37) or clipping (n = 251). Inverse probability of treatment weighting (IPTW) for the main analysis and 1:2 propensity score matching for the sensitivity analysis were used to adjust for aneurysm geometric parameters. Morbidity, major complications, and aneurysm occlusion grade were assessed at 1 year. In the IPTW analysis, no significant difference was observed in morbidity (2.1% vs. 1.6%, odds ratio [OR]: 1.34, p = 0.776) and major complications (3.3% vs. 3.1%, OR: 1.08, p = 0.926). Adequate aneurysm occlusion was achieved in 76.1% of the WEB group and 97.4% of the clipping group (OR: 0.09, p < 0.001). In line with the main analysis, the 1:2 propensity score matching analysis revealed no significant difference in the morbidity (OR: 2.00, 95% CI: 0.13–31.98, p = 0.624). This study supports that microsurgical clipping still requires to play a vital role, but WEB could be an alternative option for WNBAs in the MCA.
- Open Access
- 1 January 2025
- Published by XMLink in Korean Journal of Radiology
- Vol. 26 (7) , 716-726
FloWise Flow Diverter for Treatment of Unruptured Wide-Neck Intracranial Aneurysms: A Prospective, Multicenter, Single-Arm, Open-Label, Pivotal Study
Han HJ, et al. Korean J Radiol. 2025 Jun;26:e60. https://doi.org/10.3348/kjr.2024.1212
- 1 January 2025
- Published by XMLink in Korean Journal of Radiology
- Vol. 26 (7) , 716-726
Open AccessFloWise Flow Diverter for Treatment of Unruptured Wide-Neck Intracranial Aneurysms: A Prospective, Multicenter, Single-Arm, Open-Label, Pivotal Study
Han HJ, et al. Korean J Radiol. 2025 Jun;26:e60. https://doi.org/10.3348/kjr.2024.1212
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Korean Medical Science
- Vol. 40 (16) , e44
A Study on the Healthcare Workforce and Care for Acute Stroke: Results From the Survey of Hospitals Included in the National Acute Stroke Quality Assessment Program
Lee JY, et al. J Korean Med Sci. 2024 Dec;40(16):e44. https://doi.org/10.3346/jkms.2025.40.e44
- 1 January 2025
- Published by XMLink in Journal of Korean Medical Science
- Vol. 40 (16) , e44
Open AccessA Study on the Healthcare Workforce and Care for Acute Stroke: Results From the Survey of Hospitals Included in the National Acute Stroke Quality Assessment Program
Lee JY, et al. J Korean Med Sci. 2024 Dec;40(16):e44. https://doi.org/10.3346/jkms.2025.40.e44